MoneyWorks4Me

The sales is pegged at Rs. 4130.00 millions for the December 2022 quarter. The mentioned figure indicates decline with the sales recorded at Rs. 5295.00 millions during the year-ago period.Profit after Tax for the quarter ended December 2022 saw a decline of -47.91% from Rs. 716.00 millions to Rs. 373.00  millions.Operating Profit reported a sharp decline to 861.00 millions from 1193.00 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202203 202103 % Var
Sales 4130.00 5295.00 -22.00 15698.00 12537.00 25.21 17678.00 16535.00 6.91
Other Income 186.00 316.00 -41.14 680.00 842.00 -19.24 946.00 1011.00 -6.43
PBIDT 861.00 1193.00 -27.83 5850.00 3349.00 74.68 3076.00 5187.00 -40.70
Interest 30.00 41.00 -26.83 74.00 91.00 -18.68 133.00 113.00 17.70
PBDT 831.00 1152.00 -27.86 5776.00 3258.00 77.29 2943.00 5074.00 -42.00
Depreciation 381.00 355.00 7.32 1133.00 1028.00 10.21 1384.00 1152.00 20.14
PBT 450.00 797.00 -43.54 4643.00 2230.00 108.21 1559.00 3922.00 -60.25
TAX 77.00 81.00 -4.94 813.00 226.00 259.73 168.00 827.00 -79.69
Deferred Tax -3.00 -61.00 -95.08 -19.00 -171.00 -88.89 -157.00 -106.00 48.11
PAT 373.00 716.00 -47.91 3830.00 2004.00 91.12 1391.00 3095.00 -55.06
Equity 365.00 365.00 0.00 365.00 365.00 0.00 365.00 365.00 0.00
PBIDTM(%) 20.85 22.53 -7.47 37.27 26.71 39.51 17.40 31.37 -44.53

Natco Pharma Share Price

829.00 -9.05 (-1.08%)
04-Sep-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1899.00
Dr. Reddys Labs. 1154.00
Cipla 1385.00
Lupin 2111.00
Zydus Lifesciences 1121.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: